Boardroom Alpha
Boardroom Alpha
CRM · Current Report (Form 8-K) · Filed June 1, 2026

Salesforce Inc — Current Report (Form 8-K)

Form
8-K
Filed
June 1, 2026
Period
May 28, 2026
Ticker
CRM
Accession
0001108524-26-000131
Boardroom Alpha · Filing insights

Stockholders approved amendments to the 2013 Equity Incentive Plan and the 2004 ESPP, expanding share reserves and extending terms. Directors were elected to the board.

About Salesforce Inc
Market cap
$164.5B
1Y TSR
−31.4%
3Y TSR
−4.6%
Board grade
C+
Sector
Technology
CEO
Marc Benioff
Last annual meeting: May 28, 2026 · View full Salesforce Inc profile →
crm-20260528

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 
________________________________________________________ 
FORM 8-K
________________________________________________________
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
May 28, 2026
Date of Report (date of earliest event reported)
 _________________________________________________________
Salesforce, Inc.
(Exact name of registrant as specified in its charter) 
__________________________________________________________ 
 
Delaware001-3222494-3320693
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
Salesforce Tower
415 Mission Street, 3rd Fl
San Francisco, California 94105
(Address of principal executive offices)
Registrant’s telephone number, including area code: (415) 901-7000
N/A
(Former name or former address, if changed since last report)
_________________________________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, par value $0.001 per shareCRMNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.




Item 5.07    Submission of Matters to a Vote of Security Holders.
Salesforce, Inc. (the “Company”) held its 2026 Annual Meeting of Stockholders on May 28, 2026 (the “Meeting”). The proposals considered at the Meeting are described in the Company’s 2026 Proxy Statement filed with the Securities and Exchange Commission on April 16, 2026 (the “Proxy Statement”), and the final voting results are set forth below:

1.Election of directors:
ForAgainstAbstainBroker Non-Votes
Marc Benioff588,577,05920,946,1902,726,206102,463,325
Laura Alber602,516,3978,992,956740,102102,463,325
Amy Chang608,646,9512,872,454730,050102,463,325
Craig Conway595,222,24016,522,903504,312102,463,325
Arnold Donald602,393,5869,085,434770,435102,463,325
Parker Harris605,071,6066,725,411452,438102,463,325
David B. Kirk607,648,1954,038,035563,225102,463,325
Neelie Kroes592,988,46718,725,161535,827102,463,325
Sachin Mehra606,993,4154,754,032502,008102,463,325
Mason Morfit576,606,38735,106,845536,223102,463,325
Oscar Munoz604,377,0697,353,703518,683102,463,325
John V. Roos570,632,39740,064,9251,552,133102,463,325
Robin Washington575,435,96636,317,035496,454102,463,325

2.     Amendment and restatement of the Company’s 2013 Equity Incentive Plan to increase the number of shares reserved for issuance and extend the plan term:
ForAgainstAbstainBroker Non-Votes
463,629,512147,908,314711,629102,463,325

3.     Amendment and restatement of the Company’s 2004 Employee Stock Purchase Plan to increase the number of shares reserved for employee purchase:
ForAgainstAbstainBroker Non-Votes
609,941,6061,918,316389,533102,463,325

4.     Ratification of the appointment of Ernst & Young LLP as the Company’s independent auditor for the fiscal year ending January 31, 2027:
ForAgainstAbstainBroker Non-Votes
663,734,52149,972,0131,006,2460

5.     Advisory vote to approve the fiscal 2026 compensation of the Company’s named executive officers:
ForAgainstAbstainBroker Non-Votes
493,864,228117,716,717668,510102,463,325

6.     Stockholder proposal regarding the adoption of cumulative voting for director elections:
ForAgainstAbstainBroker Non-Votes
14,366,031595,803,8902,079,534102,463,325




Item 5.02    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
As reported above, at the Meeting, the Company’s stockholders approved an amendment and restatement of the Company’s 2013 Equity Incentive Plan (as amended and restated, the “2013 Equity Incentive Plan”) to increase the number of shares of the Company’s common stock reserved for issuance by an additional 34 million shares and to extend the termination date of the plan to March 26, 2036. The Company’s stockholders also approved an amendment and restatement of the Company’s 2004 Employee Stock Purchase Plan (as amended and restated, the “2004 Employee Stock Purchase Plan”) to increase the number of shares of the Company’s common stock reserved for employee purchase. The 2013 Equity Incentive Plan and 2004 Employee Stock Purchase Plan are described in more detail in the Proxy Statement.
The foregoing description and the summary contained in the Proxy Statement do not purport to be complete and are qualified in their entirety by reference to the full text of the 2013 Equity Incentive Plan and 2004 Employee Stock Purchase Plan, which are filed as Exhibits 10.1 and 10.2, respectively, to this Current Report on Form 8-K and incorporated herein by reference.
Item 9.01    Financial Statements and Exhibits.
(d) Exhibits
Exhibit No.Description
10.1
10.2
104Cover Page Interactive Data File—the cover page XBRL tags are embedded within the Inline XBRL document








Signature
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
Dated: June 1, 2026Salesforce, Inc.
/s/ SABASTIAN NILES
Sabastian Niles
President and Chief Legal Officer


From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Salesforce Inc (CRM)

Reference

Frequently asked questions

When did Salesforce Inc file this 8-K?
Salesforce Inc (CRM) filed this Current Report (Form 8-K) with the SEC on June 1, 2026. The accession number assigned by EDGAR is 0001108524-26-000131.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Stockholders approved amendments to the 2013 Equity Incentive Plan and the 2004 ESPP, expanding share reserves and extending terms. Directors were elected to the board. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Salesforce Inc's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Salesforce Inc has filed under CIK 1108524, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer